GFP-Rnd3 Citations (5)
Originally described in: Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification.Roberts PJ, Mitin N, Keller PJ, Chenette EJ, Madigan JP, Currin RO, Cox AD, Wilson O, Kirschmeier P, Der CJ J Biol Chem. 2008 Sep 12. 283(37):25150-63. PubMed Journal
Articles Citing GFP-Rnd3
Articles |
---|
Comparative transcriptomics reveals RhoE as a novel regulator of actin dynamics in bone-resorbing osteoclasts. Georgess D, Mazzorana M, Terrado J, Delprat C, Chamot C, Guasch RM, Perez-Roger I, Jurdic P, Machuca-Gayet I. Mol Biol Cell. 2014 Feb;25(3):380-96. doi: 10.1091/mbc.E13-07-0363. Epub 2013 Nov 27. PubMed |
Inference of Low and High-Grade Glioma Gene Regulatory Networks Delineates the Role of Rnd3 in Establishing Multiple Hallmarks of Cancer. Clarke K, Daubon T, Turan N, Soulet F, Mohd Zahari M, Ryan KR, Durant S, He S, Herbert J, Ankers J, Heath JK, Bjerkvig R, Bicknell R, Hotchin NA, Bikfalvi A, Falciani F. PLoS Genet. 2015 Jul 1;11(7):e1005325. doi: 10.1371/journal.pgen.1005325. eCollection 2015 Jul. PubMed |
The Hippo pathway mediates Semaphorin signaling. Meng Z, Li FL, Fang C, Yeoman B, Qiu Y, Wang Y, Cai X, Lin KC, Yang D, Luo M, Fu V, Ma X, Diao Y, Giancotti FG, Ren B, Engler AJ, Guan KL. Sci Adv. 2022 May 27;8(21):eabl9806. doi: 10.1126/sciadv.abl9806. Epub 2022 May 25. PubMed |
CDK9 activity switch associated with AFF1 and HEXIM1 controls differentiation initiation from epidermal progenitors. Lloyd SM, Leon DB, Brady MO, Rodriguez D, McReynolds MP, Kweon J, Neely AE, Blumensaadt LA, Ho PJ, Bao X. Nat Commun. 2022 Jul 29;13(1):4408. doi: 10.1038/s41467-022-32098-2. PubMed |
Rnd3 Is a Crucial Mediator of the Invasive Phenotype of Glioblastoma Cells Downstream of Receptor Tyrosine Kinase Signalling. Almaran B, Ramis G, Fernandez de Mattos S, Villalonga P. Cells. 2022 Nov 22;11(23):3716. doi: 10.3390/cells11233716. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.